DK1318821T3 - Væske til hæmofiltrering - Google Patents

Væske til hæmofiltrering

Info

Publication number
DK1318821T3
DK1318821T3 DK01979074T DK01979074T DK1318821T3 DK 1318821 T3 DK1318821 T3 DK 1318821T3 DK 01979074 T DK01979074 T DK 01979074T DK 01979074 T DK01979074 T DK 01979074T DK 1318821 T3 DK1318821 T3 DK 1318821T3
Authority
DK
Denmark
Prior art keywords
fluid
mmol
haemofiltration
concentration
ions
Prior art date
Application number
DK01979074T
Other languages
Danish (da)
English (en)
Inventor
Adrianus Antonius Marie Hollander
Original Assignee
Hollander Adrianus Antonius Marcus Johannes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19772121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1318821(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hollander Adrianus Antonius Marcus Johannes filed Critical Hollander Adrianus Antonius Marcus Johannes
Application granted granted Critical
Publication of DK1318821T3 publication Critical patent/DK1318821T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)
DK01979074T 2000-09-21 2001-09-21 Væske til hæmofiltrering DK1318821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1016235A NL1016235C2 (nl) 2000-09-21 2000-09-21 Vloeistof voor hemofiltratie.
PCT/NL2001/000698 WO2002024209A1 (en) 2000-09-21 2001-09-21 Fluid for haemofiltration

Publications (1)

Publication Number Publication Date
DK1318821T3 true DK1318821T3 (da) 2008-09-29

Family

ID=19772121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01979074T DK1318821T3 (da) 2000-09-21 2001-09-21 Væske til hæmofiltrering

Country Status (11)

Country Link
US (1) US20040022816A1 (de)
EP (1) EP1318821B1 (de)
AT (1) ATE397451T1 (de)
AU (1) AU2002211063A1 (de)
CY (1) CY1108251T1 (de)
DE (1) DE60134327D1 (de)
DK (1) DK1318821T3 (de)
ES (1) ES2307655T3 (de)
NL (1) NL1016235C2 (de)
PT (1) PT1318821E (de)
WO (1) WO2002024209A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101888846B (zh) 2007-10-05 2013-02-27 国立大学法人千叶大学 稳定的含碳酸氢根离子的药物溶液
DE102015015597A1 (de) * 2015-12-04 2017-06-08 Fresenius Medical Care Deutschland Gmbh Behandlung von Schlaganfall durch Hämofiltration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632913B1 (fr) 1988-06-15 1990-09-14 Bendix France Circuit hydraulique de freinage pour vehicule automobile equipe de dispositifs d'antiblocage et d'antipatinage de roues
DE3917251A1 (de) * 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
DE4122754A1 (de) * 1991-07-10 1993-01-21 Martin Prof Dr Med Vlaho Herstellung einer substitutionsloesung fuer die haemofiltration bei dialyseverfahren
US5616248A (en) * 1992-04-06 1997-04-01 Schal; Wilfried Method for the preparation of hemodialysis fluids containing bicarbonate
DE59310106D1 (de) 1993-02-19 2000-11-02 Wilfried Schael Verfahren zur Bereitung von bicarbonathaltigen Dialysierflüssigkeiten für die Hämodialyse
EP0658353A1 (de) 1993-11-19 1995-06-21 Bertold Dr. Reinhardt Pyruvathaltige CAPD- und Substitutionslösungen sowie pyruvathaltige Dialysierflüssigkeiten
SI9400289A (en) * 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.

Also Published As

Publication number Publication date
US20040022816A1 (en) 2004-02-05
NL1016235C2 (nl) 2002-03-22
ES2307655T3 (es) 2008-12-01
ATE397451T1 (de) 2008-06-15
AU2002211063A1 (en) 2002-04-02
EP1318821A1 (de) 2003-06-18
EP1318821B1 (de) 2008-06-04
WO2002024209A1 (en) 2002-03-28
PT1318821E (pt) 2008-11-13
DE60134327D1 (de) 2008-07-17
CY1108251T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
DK1025846T3 (da) Vandige flydende præparater
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE59812766D1 (de) Lösung für die Peritonealdialyse
BR9915174A (pt) Complexo de prata iÈnica
ATE66568T1 (de) Sterilisierende zusammensetzungen.
BR9916111A (pt) Derivados de fenilglicina
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
NO885836L (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opploesning.
EP1329461A4 (de) Verfahren zur verhinderung von polymeren des humanen serumalbumins
CY1108251T1 (el) Υγρο για αιμοκαθαρση
FR2866890B1 (fr) Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
DK0875248T3 (da) Anvendelse af hyaluronsyre og korresponderende salte til fremstilling af en vandig opløsning, der er velegnet som intra-artikulær skyllevæske
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NO972221L (no) Fremgangsmåte for spyttanalyse
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DK1369122T3 (da) Anticancermiddel
RU2001129744A (ru) Способ лечения бациллярных форм туберкулеза легких
RU2000105081A (ru) Применение препарата "эсвицин" для лечения ревматоидного артрита
BG45853A3 (bg) Метод за получаване на бензамидни съединения
DE69019431D1 (de) Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
RU98114539A (ru) Способ создания модели экспериментальной глаукомы
RU2000121700A (ru) Способ лечения остеохондропатий
ES2060030T3 (es) Un metodo de desactivacion de una solucion consistente en un biocida organofosforado.